PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of saudimedjLink to Publisher's site
 
Saudi Med J. 2016 June; 37(6): 607–612.
PMCID: PMC4931640

The potential role of microbes in oncogenesis with particular emphasis on oral cancer

Abstract

For over a century, non-virus microorganisms, notably bacteria have been implicated as causal agents of cancers, a relatively small number of researchers have provided evidence to support the so-called “cancer germ” hypothesis. With the exception of the link between Helicobacter pylori and stomach cancer, other supposed links have been ignored. A wide range of bacteria and other non-virus microbes, including fungi, have been implicated over the years in oncogenesis, as well as the ability to induce inflammation, which may cause cancer. It seems that there is no single “cancer germ,” as most bacteria can apparently induce cancer. Here, the role of bacteria and other non-virus microorganisms and oral cancers will be discussed. By ignoring bacteria as a causal agent of cancer, we set back our understanding of this crucially important disease and, as a result, have hindered the development of potential cures.

Although historical and more recent evidence shows that bacteria and other non-virus microbes play a role in oncogenesis, most of the cancer research community is unaware of, or else has dismissed, this potentially crucial association; this is certainly the case with oral cancer. The aim of this review is to highlight the role bacteria plays in cancer in general, and specifically in oral cancer. Oral cancer is the sixth most prevalent cancer worldwide and is particularly common in developing countries. For example, in Southeast Asia, approximately 40% of all malignancies are located within the oral cavity,1 most of which are mainly squamous cell carcinomas (SCCs) that originate from the oral mucosa.2 The mean all-stage survival rate for oral cancer over a 5 year period is <50%, with an annual mortality rate similar to that of malignant melanomas and cancers of the cervix.3 The incidence of oral cancer is increasing worldwide, including in the United Kingdom4 and in Saudi Arabia.5 The male-to-female ratio has recently reduced significantly, whereas the number of cases in patients under 45 has increased remarkably.3

Bacteria and cancer

Historical reports of an etiological association between bacteria and cancer have been made from the mid-eighteen hundreds. In fact, almost as soon as the link was made between microorganisms, including fungi,6,7 and bacteria, and disease,8,9 Dudgeon & Dunkley reported that Doyen in 1886 has isolated a bacterium10 for example, isolated a bacterium from 90% of the tumors he examined. This isolate was identified as Micrococcus neoformans and was subsequently shown to be a species of Staphylococcus. Doyen10 then went on to prepare a vaccine from the isolate and claimed it could cure cancer.10 Additionally, Cantwell 1990 has reported that Glover in 1926 managed to isolate a specific bacterium from neoplastic tissue and created a serum which allegedly produced remarkable improvements in half of all treated cases.11 Finally, a large number of non-virus microorganisms other than bacteria were also associated with human cancers, including species of protozoa and fungi (including yeasts), and members of every generation of microbiologists since the early days of interest in the supposed cancer germ hypothesis have reported a link between non-virus microbes and cancer.7 Since this link was established over a century ago, the role of non-virus microbes in cancer has not been fully accepted. However, in addition to the scientific problems relating to its establishment, there are cultural reasons why the cancer germ hypothesis has not yet been accepted, and, as we shall see, even with increasing amounts of modern evidence based on the use of sophisticated, molecular identification techniques which support the link, the cancer community (including cancer charities) is either unaware of the association between non-virus microbes, notably bacteria, and cancer, or else chooses to ignore it.

In the twentieth century, Virgina Wuerthele as mentioned by Cantwell in 2005, isolated a bacterium, which she termed Progenitor cryptoides, that again claimed to generate a supposed cancer-curing vaccine.12 Since such vaccines are obviously not in use today, they clearly must have been ineffective or, at best, variable. The main modern champions of the cancer germ hypothesis are Cantwell,11,12 and Wainwright,6,7,13-16 both of whom have provided evidence linking microbes with cancer and have attempted to convince the wider scientific and medical community of this possibility via various media outlets. Wainwright and Al Talhi,16 published a study highlighting the isolation of a highly pleomorphic bacterium (Bacillus licheniformis) from a canine mammary tumor, which they suggested might be one of the cancer germs described in the early literature. A notable feature of this pleomorphic isolate is its ability to exist as bacterial rods and cocci as well as what appears to be frank fungus. Upon closer inspection; however, this “fungus” turns out to be a complex bacterial form that mimics a mass of hyphae and spores. It goes without saying that the ability of a tumor-isolated bacterium to present itself as a fungus, or as different bacterial forms, has caused considerable confusion among clinical bacteriologists, leading to claims that pleomorphic, cancer-isolated bacteria are contaminants or, at best, exist as mixed cultures. The ability of cancer-related bacteria to be pleomorphic is perhaps the single most important factor that has delayed the recognition of the ability of bacteria to play a role in carcinogenesis. This fact lead Wainwright14 to title one of his papers on the subject, “When heresies collide: Extreme bacterial pleomorphism and the cancer germ,” with the heresies being: a) the existence of cancer-causing bacteria, and b) the ability of such bacteria to exist in widely different pleomorphic forms.

Another feature of the cancer germ hypothesis is the claim by cancer germ advocates that bacteria can live intracellularly, or even within the nucleus and are able to act as persisters, existing dormant for long periods within the host cell. Such claims may help explain why cancer is often associated with old age, namely, aging cells. Wainwright17 also suggested that, due to their sub-micron size, nanobacteria can readily enter human cells and nuclei and may be particularly active in inducing cancers. While most people are happy to accept that viruses are involved in carcinogenesis due to their small size and seemingly “mysterious nature,” bacteria tend to be considered prosaic organisms that seem to be incapable of inducing cancer. This presents us with yet another factor that helps to explain why the cancer germ hypothesis has long been neglected.

By far the most important discovery in relation to the cancer germ hypothesis came in the mid-1919’s with the demonstration by Marshall 1995,18 that the bacterium, Helicobacter pylori (H. pylori), causes gastritis, which, in some cases, can lead to serious inflammation that causes gastric cancer.19,20 Despite what is often thought, however, H. pylori is not the only bacterium (or non-virus microbe) that has recently been associated with cancer. Recent studies21 reported that Escherichia coli (E. coli) and species of Salmonella systematically hone in on tumors where they replicate. Bacteria have also been associated with pancreatic cancers,22 and some lung cancers are associated with Chlamydia-based pneumonia infections wherein inflammation is again the mechanism that leads to cancer development.23 Notably, even as early as the 1920’s, researchers linked the carcinogenic effect of microbes to this hypothesis.15 Other recent links between bacteria and human cancers include the association between Salmonella typhi and both hepatobillary carcinoma,24 and gall bladder cancer,25 presumably due to its ability to convert bile salts to carcinogenic compounds.26 Finally, an association between Streptococcus bovis and colorectal cancer (CRC) has also been shown,27,28 which is possibly related to the production of pro-inflammatory chemokines.29 As we have seen throughout more than 150 years of the cancer germ hypothesis, workers have claimed that cancer-causing bacteria are generally highly pleomorphic organisms. It is particularly noteworthy then that modern researchers have linked human cancers to a number of pleomorphic bacteria including, H. pylori and Fusobacterium, which are linked to CRC,30 and Chlamydia trachomatis, which is associated with cervical cancer,26 all of which are pleomorphic bacteria.

Oral bacteria and cancer

The association between microbes in the oral cavity and various types of cancers (Table 1) is becoming increasingly more recognized.31,32 The microflora of the oral cavity includes a complex array of bacteria living in a balanced immune-inflammatory state with the host-patient, often existing in biofilms.33 A variety of microorganisms have been associated with oral cancers, including Exiguobacterium oxidotolerans, Prevotella melaninogenica, Staphylococcus aureus, Veillonella parvula, and species of Micrococcus.34 Other isolates found in oral cancers include yeasts, actinomycetes, Bifidobacteria, lactobacilli, and streptococci.35 These are typically acidophilic organisms, which is not surprising since the micro-environment of solid tumors is generally hypoxic with a low pH, which favors the growth and survival of acid-tolerant bacteria.36 Streptococcus anginosus has been particularly singled out as a potential causal agent of oral cancers largely due to its ability to induce inflammation.37 Streptococcus anginosus is also associated with esophageal, gastric, and pharyngeal cancers.38,39 Bacteria such as Porphyromonas gingivalis (P. gingivalis) are implicated in oral cancers40 and interfere with this oral flora equilibrium, bringing the unbalanced host-bacteria relationships that allow organisms, such as Fusobacterium nucleatum (F. nucleatum), to become dominant, opportunistic pathogens that cause periodontal disease. This series of events commonly occurs in patients with impaired immune systems and is becoming increasingly associated with the formation of oral cancers.33 Viruses have also been widely implicated as a cause of oral cancers. Notably, Epstein barr virus (EBV) and human papilloma viruses (HPV)41 as well as fungi, such as Candida albicans,11 have all been associated with oral cancers. Chronic oral candidiasis often involves invasion of fungal hyphae into the oral epithelium, which leads to dysplastic changes and ultimately cancer.42 Moreover, oral squamous cell carcinomas (OSCCs) also often contain higher numbers of Porphyromonas and Fusobacterium than do cells of nearby healthy mucosal membranes.42 Several recent studies43,44 have also shown a strong association between F. nucleatum and CRC, this bacterium is commonly found within, and close to CRC neoplasms, and it is frequently associated with lymph node metastases.

Table 1
The association between microbes in the oral cavity and various types of cancers.

A variety of mechanisms have been suggested to explain how bacteria cause cancer. These include a) causing chronic infections, which lead to the production of toxins that then disturb the cell cycle and bring about altered cell growth,45 b) infections can result in intracellular deposition of the pathogen, resulting in suppression of apoptosis via modulation of the expression of Bcl-2 family proteins, or inactivation of the retinoblastoma protein, pRb,46 a set of circumstances that provides a niche that facilitates the survival of intracellular pathogens despite the immune system’s attempts to destroy them by apoptosis, c) chronic infections induce cell proliferation and DNA replication by mitogen activated protein kinase (MAPK) pathways and cyclin D1, thereby increasing the incidence of cell transformation and the rate of tumor development, which result from enhanced genetic mutation,47 d) pathogenic bacteria can cause chronic infections and subvert host cell signaling pathways, enhancing the survival of the pathogen,26 e) bacteria can convert ethyl alcohol to acetaldehyde, which is carcinogenic by virtue of its ability to cause epithelial DNA damage, mutagenesis, and secondary hyper-proliferative epithelium,48,49 and f) microbial carcinogenesis may also involve nitrosation by which microbes produce N-nitroso compounds from nitrites, amines, and amides. Filamentous fungi, many yeasts, and several bacterial species, including common species such as E. coli,48 can catalyze nitrosation, and the production of carcinogenic nitrosamines appears to be particularly linked to cancer development in the oral cavity.50 It is possible, however, that undetected cancers or precancerous lesions enhance the colonization and growth of oral bacteria and that these play no direct role in carcinogenesis.

Chronic inflammation has long been suggested as a factor that contributes tumor development.51 For example, both P. gingivalis and F. nucleatum can cause chronic infections by persisting intracellularly within epithelial cells and initiating inflammatory responses. They can also spread systemically and cause infections beyond the oral cavity where they can cause major disruptions of the host’s immune response mechanisms.52 Fusobacterium nucleatum is markedly pro-inflammatory, and McCoy et al43 pointed to a positive correlation between mRNA levels for several local cytokines and Fusobacterium species in CRC cases. Fusobacterium nucleatum produces a pro-inflammatory microenvironment, which enhances the development of CRC.53 Porphyromonas gingivalis can also induce both pro- and anti-inflammatory effects, and in addition to general immune-disruptive effects, both P. gingivalis and F. nucleatum negatively impact a number of aspects of epithelial cell signaling, all of which are factors that are directly related to the development and progression of cancer.54

The oral cavity can be regarded a microbial niche that is home to numerous microbial communities made up of a variety of different organisms that exist in homeostasis with one another.33 Certain bacteria within this community can affect the ability of the host to carry out immune surveillance, and, as a result, the oral microbiota enters a state of dysbiosis.55 Under these new dysbiotic environmental pressures, previously commensal bacteria in the oral cavity, such as F. nucleatum, become opportunistic pathogens.9 A positive correlation exists between the presence of Fusobacterium species and the mRNA levels of a variety of inflammatory cytokines, thereby demonstrating that these bacteria are potent inducers of inflammation.43 These bacteria can also elevate levels of cell proliferation and migration by targeting signaling molecules, specifically kinases involved in cell cycle control.34 Subsequent activation of the p38 protein by these kinases leads to the secretion of matrix metalloproteins 9 and 13, both of which play critical roles in the invasion and metastasis of tumors.52 As a result, F. nucleatum acts as a potent pro-inflammatory agent and creates an environment in which the progression of cancer is highly favored.

Of course, it is also possible that bacteria enter tumors post tumorigenesis, as these organisms may have an affinity for the conditions that are created as the tumor develops.8 Therefore, to confirm if a bacterial infection causes cancer, extensive research is required, specifically epidemiological studies linking the organism with cancer, molecular analysis of suspected pro-oncogenic virulence factors or toxins produced by the organism, and finally in vivo animal models where cancer can be monitored post-infection.

In conclusion, it is clear that the so-called cancer germ hypothesis has a very long history and that microbiologists and cancer researchers of every generation have reported such a link. Despite this however, bacteria are currently not widely accepted as a major cause of cancer. An exception to this notion is the role played by H. pylori in stomach cancers.19 Strangely, the emphasis that has been placed on the ability of this bacterium to induce carcinogenesis has overshadowed the potential role of other bacteria in this process. It is as if H. pylori has been elevated to a “super-bacterium,” which alone, amongst bacteria, can cause cancer. Simply put, if H. pylori can cause cancer, then there is no reason why other seemingly common place bacteria cannot do so also. The original supporters of the cancer germ hypothesis, including James Young, were clear in their minds that bacteria and other non-virus microbes cause cancer by initiating inflammation.15 The cancer germ hypothesis states that a) bacteria and other non-virus microbes cause cancer in human and animals, b) there is no single “cancer germ,” but that most, if not all, bacteria, even commonplace species such as E. coli and S. aureus can induce cancer, and c) that bacteria exist both intracellularly and within the nucleus as persisters where they can evade the patient’s immune system for very long periods of time, a fact which helps explain why cancer is a disease of old age. Essentially the theory claims that any microbe can cause cancer in humans if it is in the right place at the right time. If this is the case, then it suggests that it will be difficult to prevent or cure cancers if they have a microbial origin because no antibiotic can kill all bacteria. Additionally, it is impossible to sterilize the body completely, especially if the bacteria that induce cancer persist unseen by the immune system. Alternatively, it may be possible to develop vaccines against the main cancer-inducing bacteria. From the current standpoint, however, it seems that even if the cancer germ hypothesis is fully established, it will not necessarily lead to cure quickly. However, knowledge is power, and once the role that bacteria and other non-virus microbes play in human cancers, including oral cancer, is established, it will undoubtedly provoke increased efforts to produce a cure using many research avenues, including those that have not yet been defined.

Acknowledgement

We would like to thank the Research Center of the Female Scientific and Medical Colleges, Deanship of Scientific Research, King Saud University, Riyadh, Kingdom of Saudi Arabia.

Footnotes

Disclosure. Authors have no conflict of interests, and the work was not supported or funded by any drug company.

Copyright

Whenever a manuscript contains material (tables, figures, etc.) which is protected by copyright (previously published), it is the obligation of the author to obtain written permission from the holder of the copyright (usually the publisher) to reproduce the material in Saudi Medical Journal. This also applies if the material is the authors own work. Please submit copies of the material from the source in which it was first published.

References

1. Rodrigues VC, Moss SM, Tuomainen H. Oral cancer in the UK: to screen or not to screen. Oral Oncol. 1998;34:454–465. [PubMed]
2. Chen AY, Myers JN. Cancer of the oral cavity. Curr Probl Surg. 2000;37:633–731. [PubMed]
3. Silverman S., Jr . Oral Cancer (American Cancer Society Atlas of Clinical Oncology) 5th ed. Shelton (CT): PMPH USA; 2003.
4. Hindle I, Downer MC, Moles DR, Speight PM. Is alcohol responsible for more intra-oral cancer? Oral Oncol. 2000;36:328–333. [PubMed]
5. Brown KR. The unequal burden related to the risk of oral cancer in the different regions of the Kingdom of Saudi Arabia. Community Dent Health. 2006;23:101–106. [PubMed]
6. Wainwright M. Do fungi play a role in the aetiology of cancer? Reviews in Medical Microbiology. 2002;13:37–42.
7. Wainwright M. The overlooked link between non-virus microbes and cancer. Sci Prog. 2010;93:393–402. [PubMed]
8. Mager D. Bacteria and cancer: cause, coincidence or cure? A review. J Transl Med. 2006;28:14. [PMC free article] [PubMed]
9. Schwabe RF, Jobin C. The microbiome and cancer. Nat Rev Cancer. 2013;13:800–812. [PMC free article] [PubMed]
10. Dudgeon LS, Dunkley EV. The Micrococcus neoformans. Epidemiol Infect. 1906;7:13–21. [PMC free article] [PubMed]
11. Cantwell A. The cancer microbe. Los Angeles (CA): Aries Rising Press; 1990. p. 283.
12. Cantwell A. Four women against cancer. Los Angeles (CA): Aries Rising Press; 2005. p. 144.
13. Wainwright M. Hypothesis-can UV produced by intracellular bacteria cause cancer? Microbiology. 1998;144(Pt 12):3239–3240. [PubMed]
14. Wainwright M, De Wulf P, Tao T, Grulich P, Kucharski L, Smith R. When heresies collide - extreme bacterial pleomorphism and the cancer germ. Microbiology. 1998;144:595–596. [PubMed]
15. Wainwright M. James Young and the “cancer germ” J Med Biogr. 1998;6:203–205. [PubMed]
16. Wainwright M, Al Talih A. Is this the historical “cancer germ”? Med Hypotheses. 2003;60:290–292. [PubMed]
17. Wainwright M. Nanobacteria and associated ‘elementary bodies’ in human disease and cancer. Microbiology. 1999;145:2623–2624. [PubMed]
18. Marshall BJ. The 1995 Albert Lasker Medical Research Award Helicobacter pylori. The etiologic agent for peptic ulcer. JAMA. 1995;274:1064–1066. [PubMed]
19. Kim SS, Ruiz VE, Carroll JD, Moss SF. Helicobacter pylori in the pathogenesis of gastric cancer and gastric lymphoma. Cancer Lett. 2011;305:228–238. [PMC free article] [PubMed]
20. Crowe SE. Helicobacter infection, chronic inflammation, and the development of malignancy. Curr Opin Gastroenterol. 2005;21:32–38. [PubMed]
21. Morrissey D, O’Sullivan G, Tangney M. Tumour targeting with systemically administered bacteria. Curr Gene Ther. 2010;10:3–14. [PubMed]
22. Michaud DS. Role of bacterial infections in pancreatic cancer. Carcinogenesis. 2013;34:2193–2197. [PMC free article] [PubMed]
23. Koyi H, Brandén E, Gnarpe J, Gnarpe H, Steen B. An association between chronic infection with Chlamydia pneumoniae and lung cancer. A prospective 2-year study note. APMIS. 2001;109:72–80. [PubMed]
24. Welton J, Marr J, Friedman S. Association between hepatobiliary cancer and typhoid carrier state. Lancet. 1979;313:791–794. [PubMed]
25. Ferreccio C. Salmonella typhi and Gallbladder cancer. In: Khan AA, editor. Bacteria and cancer. Dordrecht (NL): Springer; 2012. pp. 117–137.
26. Lax AJ, Thomas W. How bacteria could cause cancer: one step at a time. Trends Microbiol. 2002;10:293–299. [PubMed]
27. Ellmerich S, Schöller M, Duranton B, Gossé F, Galluser M, Klein JP, et al. Promotion of intestinal carcinogenesis by Streptococcus bovis. Carcinogenesis. 2000;21:753–756. [PubMed]
28. zur Hausen H. Streptococcus bovis: Causal or incidental involvement in cancer of the colon? Int J Cancer. 2006;1(119):xi–xii. [PubMed]
29. Gately S. The contributions of cyclooxygenase-2 to tumor angiogenesis. Cancer Metastasis Rev. 2000;19:19–27. [PubMed]
30. Viljoen KS, Dakshinamurthy A, Goldberg P, Blackburn JM. Quantitative profiling of colorectal cancer-associated bacteria reveals associations between fusobacterium spp., enterotoxigenic Bacteroides fragilis (ETBF) and clinicopathological features of colorectal cancer. PloS One. 2015;10:e0119462. [PMC free article] [PubMed]
31. Hooper SJ, Crean SJ, Fardy MJ, Lewis MA, Spratt DA, Wade WG, et al. A molecular analysis of the bacteria present within oral squamous cell carcinoma. J Med Microbiol. 2008;56:1651–1659. [PubMed]
32. Hooper SJ, Wilson MJ, Crean SJ. Exploring the link between microorganisms and oral cancer: a systematic review of the literature. Head Neck. 2009;31:1228–1239. [PubMed]
33. Hajishengallis G, Lamont RJ. Beyond the red complex and into more complexity: the polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology. Mol Oral Microbiol. 2012;27:409–419. [PMC free article] [PubMed]
34. Whitmore SE, Lamont RJ. Oral bacteria and cancer. PLoS Pathog. 2014;10:e1003933. [PMC free article] [PubMed]
35. Chocolatewala N, Chaturvedi P, Desale R. The role of bacteria in oral cancer. Indian J Med Paediatr Oncol. 2010;31:126–131. [PMC free article] [PubMed]
36. Raghunand N, Gatenby RA, Gillies RJ. Microenvironmental and cellular consequences of altered blood flow in tumors. Br J Radiol. 2003;76:S11–S22. [PubMed]
37. Rakoff-Nahoum S. Why cancer and inflammation? Yale J Biol Med. 2006;79:123–130. [PMC free article] [PubMed]
38. Sasaki H, Ishizuka T, Muto M, Nezu M, Nakanishi Y, Inagaki Y, et al. Presence of Streptococcus anginosus DNA in esophageal cancer, dysplasia of esophagus, and gastric cancer. Cancer Res. 1998;58:2991–2995. [PubMed]
39. Shiga K, Tateda M, Saijo S, Hori T, Sato I, Tateno H, et al. Presence of Streptococcus infection extra-orpharyngeal head neck squamous cell carcinoma and its implication in carcinogenesis. Oncol Rep. 2001;8:245–248. [PubMed]
40. Katz J, Onate MD, Pauley KM, Bhattacharyya I, Cha S. Presence of Porphyromonas gingivalis in gingival squamous cell carcinoma. Int J Oral Sci. 2011;3:209–215. [PMC free article] [PubMed]
41. Moore PS, Chang Y. Why do viruses cause cancer?Highlights of the first century of human tumour virology. Nat Rev Cancer. 2010;10:878–889. [PMC free article] [PubMed]
42. Nagy KN, Sonkodi I, Szöke I, Nagy E, Newman HN. The microflora associated with human oral carcinomas. Oral Oncol. 1998;34:304–308. [PubMed]
43. McCoy AN, Araújo-Pérez F, Azcárate-Peril A, Yeh JJ, Sandler RS, Keku TO. Fusobacterium is associated with colorectal adenomas. PLoS ONE. 2013;8:e53653. [PMC free article] [PubMed]
44. Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 2012;22:299–306. [PubMed]
45. Yilmaz Ö, Yao L, Maeda K, Rose TM, Lewis EL, Duman M, et al. ATP scavenging by the intracellular pathogen Porphyromonas gingivalis inhibits P2X7-mediated host-cell apoptosis. Cell Microbiol. 2008;10:863–875. [PMC free article] [PubMed]
46. Nougayrède JP, Taieb F, Rycke JD, Oswald E. Cyclomodulins: bacterial effectors that modulate the eukaryotic cell cycle. Trends Microbiol. 2005;13:103–110. [PubMed]
47. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860–867. [PMC free article] [PubMed]
48. Calmels S, Ohshima H, Vincent P, Gounot AM, Bartsch H. Screening of microorganisms for nitrosation catalysis at pH 7 and kinetic studies on nitrosamine formation from secondary amines by E. coli strains. Carcinogenesis. 1985;6:911–915. [PubMed]
49. Salaspuro MP. Acetaldehyde, microbes, and cancer of the digestive tract. Crit Rev Clin Lab Sci. 2003;40:183–208. [PubMed]
50. Lijinsky W. Species specificity in nitrosamine carcinogenesis. In: Langenbach R, Nesnow S, Rice JM, editors. Organ and species specificity in chemical carcinogenesis. New York (NY): Springer-Verlag; 1983. pp. 63–75.
51. Biarc J, Nguyen IS, Pini A, Gossé F, Richert S, Thiersé D, et al. Carcinogenic properties of proteins with pro-inflammatory activity from Streptococcus infantarius (formerly S. bovis ) Carcinogenesis. 2004;25:1477–1484. [PubMed]
52. Han YW, Wang X. Mobile microbiome: oral bacteria in extra-oral infections and inflammation. J Dent Res. 2013;92:485–491. [PMC free article] [PubMed]
53. Kostic AD, Gevers D, Pedamallu CS, Michaud M, Duke F, Earl AM, et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 2012;22:292–298. [PubMed]
54. Takeuchi H, Hirano T, Whitmore SE, Morisaki I, Amano A, Lamont RJ. The Serine phosphatase SerB of Porphyromonas gingivalis suppresses IL-8 production by dephosphorylation of NF-kB RelA/p65. PLoS Pathog. 2013;9:e1003326. [PMC free article] [PubMed]
55. Kerr AR. The oral microbiome and cancer. J Dent Hyg. 2015;89:20–23. [PubMed]

Articles from Saudi Medical Journal are provided here courtesy of Saudi Medical Journal